Reflecting the enormous changes that have taken place since the publication of the first edition, Statistics in the Pharmaceutical Industry, Second Edition covers new topics such as cancer clinical trials, clinical trials of AIDS patients, and animal tumorigenicity studies . . . the development of antiepileptic drugs . . . the role of epidemiology in postmarketing trials and adverse drug experience . . . Computer-Assisted New Drug Application (CANDA) submissions . . . contract research organizations . . . interim analysis in clinical trials . . . room-temperature tests for the stability of drugs . . . and much more! This entirely rewritten, thoroughly updated Second Edition of an invaluable reference/text remains the source for balanced, comprehensive information on the wide-ranging applications of statistics in the pharmaceutical field - bridging the gap between industry and academia and focusing on practical aspects.